Agenus to Participate in February Investor Conferences

January 26, 2023

https://www.globenewswire.com/news-release/2023/01/26/2595941/8060/en/Agenus-to-Participate-in-February-Investor-Conferences.html

LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) — Agenus (NASDAQ:AGEN), an immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today announced that Dr. Garo Armen, Chairman and CEO, and Dr. Steven O’Day, Chief Medical Officer, will participate in the following upcoming investor conferences:

Read more at globenewswire.com

Related news for (AGEN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.